Calcimedica, Common Stock Stock Performance
| CALC Stock | 2.78 0.03 1.07% |
The firm shows a Beta (market volatility) of 1.2, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, CalciMedica, Common will likely underperform. At this point, CalciMedica, Common Stock has a negative expected return of -0.46%. Please make sure to confirm CalciMedica, Common's treynor ratio, accumulation distribution, price action indicator, as well as the relationship between the potential upside and day median price , to decide if CalciMedica, Common Stock performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days CalciMedica, Common Stock has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's essential indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
Actual Historical Performance (%)
One Day Return (1.07) | Five Day Return (1.77) | Year To Date Return (9.30) | Ten Year Return (52.40) | All Time Return (52.40) |
Last Split Factor 1:14 | Last Split Date 2023-03-20 |
1 | Acquisition by Eric Roberts of 45543 shares of CalciMedica, Common at 5.36 subject to Rule 16b-3 | 09/30/2024 |
2 | CalciMedica Announces Upcoming Late-Breaker Plenary Presentation at the American College of Gastroenterology 2024 Annual Scientific Meeting | 10/16/2024 |
3 | Acquisition by Middleton Fred A of 13184 shares of CalciMedica, Common at 3.702 subject to Rule 16b-3 | 10/25/2024 |
4 | Why Carvana Shares Are Trading Higher By Around 20 Here Are 20 Stocks Moving Premarket | 10/31/2024 |
5 | Acquisition by Wilson Robert N of 53333 shares of CalciMedica, Common at 3.75 subject to Rule 16b-3 | 11/01/2024 |
6 | CalciMedica sees significant stock purchase by Sanderling Ventures | 11/05/2024 |
7 | Fred A. Middleton Purchases 87,744 Shares of CalciMedica, Inc. Stock | 11/07/2024 |
8 | CalciMedica GAAP EPS of -0.50 | 11/13/2024 |
9 | CalciMedica to Participate in the Piper Sandler 36th Annual Healthcare Conference | 11/21/2024 |
10 | Acquisition by Middleton Fred A of 4800 shares of CalciMedica, Common at 2.65 subject to Rule 16b-3 | 12/06/2024 |
11 | Insider Activity Roundup Fridays Key Buys and Sells in US Stocks | 12/09/2024 |
| Begin Period Cash Flow | 1.5 M |
CalciMedica, |
CalciMedica, Common Relative Risk vs. Return Landscape
If you would invest 414.00 in CalciMedica, Common Stock on September 19, 2024 and sell it today you would lose (136.00) from holding CalciMedica, Common Stock or give up 32.85% of portfolio value over 90 days. CalciMedica, Common Stock is currently does not generate positive expected returns and assumes 5.7288% risk (volatility on return distribution) over the 90 days horizon. In different words, 51% of stocks are less volatile than CalciMedica,, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
CalciMedica, Common Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CalciMedica, Common's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as CalciMedica, Common Stock, and traders can use it to determine the average amount a CalciMedica, Common's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0802
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CALC |
Estimated Market Risk
| 5.73 actual daily | 51 51% of assets are less volatile |
Expected Return
| -0.46 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average CalciMedica, Common is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CalciMedica, Common by adding CalciMedica, Common to a well-diversified portfolio.
CalciMedica, Common Fundamentals Growth
CalciMedica, Stock prices reflect investors' perceptions of the future prospects and financial health of CalciMedica, Common, and CalciMedica, Common fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CalciMedica, Stock performance.
| Return On Equity | -0.84 | ||||
| Return On Asset | -0.65 | ||||
| Current Valuation | 17.09 M | ||||
| Shares Outstanding | 13.48 M | ||||
| Price To Book | 4.08 X | ||||
| EBITDA | (34.19 M) | ||||
| Net Income | (34.36 M) | ||||
| Total Debt | 4.03 M | ||||
| Book Value Per Share | 1.42 X | ||||
| Cash Flow From Operations | (25.73 M) | ||||
| Earnings Per Share | (1.11) X | ||||
| Market Capitalization | 37.88 M | ||||
| Total Asset | 12.19 M | ||||
| Retained Earnings | (146.06 M) | ||||
| Working Capital | 7.58 M | ||||
About CalciMedica, Common Performance
By analyzing CalciMedica, Common's fundamental ratios, stakeholders can gain valuable insights into CalciMedica, Common's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CalciMedica, Common has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CalciMedica, Common has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (314.81) | (330.55) | |
| Return On Tangible Assets | (2.82) | (2.68) | |
| Return On Capital Employed | (2.68) | (2.82) | |
| Return On Assets | (2.82) | (2.68) | |
| Return On Equity | (4.21) | (4.00) |
Things to note about CalciMedica, Common Stock performance evaluation
Checking the ongoing alerts about CalciMedica, Common for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CalciMedica, Common Stock help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CalciMedica, Common generated a negative expected return over the last 90 days | |
| CalciMedica, Common has high historical volatility and very poor performance | |
| CalciMedica, Common has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (34.36 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| CalciMedica, Common generates negative cash flow from operations | |
| CalciMedica, Common has a frail financial position based on the latest SEC disclosures | |
| About 17.0% of the company shares are held by company insiders | |
| Latest headline from investing.com: Insider Activity Roundup Fridays Key Buys and Sells in US Stocks |
- Analyzing CalciMedica, Common's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CalciMedica, Common's stock is overvalued or undervalued compared to its peers.
- Examining CalciMedica, Common's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CalciMedica, Common's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CalciMedica, Common's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CalciMedica, Common's stock. These opinions can provide insight into CalciMedica, Common's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for CalciMedica, Stock analysis
When running CalciMedica, Common's price analysis, check to measure CalciMedica, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CalciMedica, Common is operating at the current time. Most of CalciMedica, Common's value examination focuses on studying past and present price action to predict the probability of CalciMedica, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CalciMedica, Common's price. Additionally, you may evaluate how the addition of CalciMedica, Common to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |